Search clinical trials for: Urge Incontinence

Total 5636 results

University of North Carolina, Chapel Hill
National Institute on Aging (NIA)

Completed

Understanding the Response to Fesoterodine Through Genetic Evaluation in the Elderly (URGE) (URGE)

Urge Urinary Incontinence

United States
Prof. Dr. Volker Viereck

Completed

Mixed Urinary Incontinence Symptoms Before and After Treatment With Botox and Bulkamid

Mixed Incontinence, Urge and Stress

Switzerland
Velicept Therapeutics, Inc.

Completed

Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women

Overactive Bladder

United States
Velicept Therapeutics, Inc.

Completed

A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) (VEL-2001)

Overactive Bladder

United States
Turku University Hospital

Completed

Tension-free Vaginal Tape Obturator for the Treatment of Urinary Incontinence -Long-term Follow-up

Urinary Incontinence, Urge | Urinary Incontinence,Stress
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder (Symphony)

Urologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases | Urological Manifestations | Signs and Symptoms

Belarus, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
Oregon Health and Science University

Completed

Examining Bladder Control Using Mindful Based Approach

Urinary Urgency Incontinence

United States
Sciton

Completed

Hybrid Fractional Laser Treatment for Symptoms of Urinary Incontinence

Urinary Incontinence | Stress Urinary Incontinence | Urge Incontinence

United States
Loyola University
Astellas Pharma US, Inc.

Completed

Incontinence & Intimate Partners: Assessing the Contribution of Treatment (IIMPACT)

Urge Urinary Incontinence

United States
University of Michigan
Arbor Research Collaborative for Health; Blue Cross Blue Shield of Michigan...

Completed

Fluids Affecting Bladder Urgency and Lower Urinary Symptoms (FABULUS)

Alcohol Drinking | Overactive Bladder | Urinary Bladder, Overactive | Lower Urinary Tract Symptoms | Urinary Incontinence, Urge | Caffeine | Urinary Urgency

United States
University of California, San Francisco
National Institute on Aging (NIA)

Completed

Controlling Urgency Through Relaxation Exercises (CURE)

Overactive Bladder | Urgency Incontinence | Urgency Urinary Symptoms

United States
University of North Carolina, Chapel Hill
Allergan

Withdrawn

Effects of Eluxadoline (Viberzi®) 100 mg Twice Daily on Diarrhea-Associated Fecal Incontinence (ELXDFI)

Diarrhea | Fecal Incontinence | Urge Incontinence | Anal Incontinence | Accidental Bowel Leakage
University of Southern California

Terminated

Group Medical Visits for Latina Women With Urgency Urinary Incontinence

Overactive Bladder | Urge Incontinence | Urinary Urgency

United States
University College London Hospitals

Unknown

Assessment of Faecal Incontinence With MAPLe

Fecal Incontinence | Faecal Incontinence | Faecal Incontinence With Faecal Urgency

United Kingdom
R-Pharm
Synergy Research Inc.

Completed

Efficacy and Safety Evaluating Study to Compare Uritos® (Imidafenacin) and Urotol® (Tolterodine) for Treatment of Overactive Bladder.

Overactive Bladder

Russian Federation
Axonics Modulation Technologies, Inc.

Active, not recruiting

Axonics SacRal NeuromodulaTIon System for Urinary Urgency Incontinence TreatmeNt (ARTISAN-SNM)

Urinary Incontinence, Urge

Netherlands, United States, United Kingdom
University of New Mexico
National Center for Complementary and Integrative Health (NCCIH)

Completed

Brain-Centered Therapy Versus Medication for Urgency Urinary Incontinence : Hypnotherapy Or Pharmacotherapy (Hyp-hOP)

Urinary Incontinence, Urge

United States
University of California, San Francisco

Completed

Treatment of Incontinence Without Memory Problems (TRIUMPH)

Urge Incontinence | Urinary Incontinence, Urge

United States
University of Utah

Completed

Comparing Approaches to Treat Older Adult Women's Urge Incontinence: Pilot Feasibility and Randomized Controlled Trial (SHUW)

Urinary Incontinence, Urge | Urinary Incontinence in Old Age

United States
Astellas Pharma Europe Ltd.

Completed

A Prospective Non-interventional Study in Overactive Bladder (OAB) Patients Prescribed Betmiga® as Part of Routine Clinical Practice (BELIEVE)

Urologic Diseases | Overactive Bladder | Urinary Bladder Diseases | Urgency Incontinence | Urinary Bladder Overactive

Czechia, Denmark, Greece, Ireland, Slovakia, Spain, Sweden, United Kingdom
MedtronicNeuro

Terminated

Efficacy Study of Pudendal Neuromodulation for the Treatment of Neurogenic Overactive Bladder (ACCEPTANCE)

Urinary Incontinence | Detrusor Overactivity | Neurogenic Overactive Bladder

Belgium, France, United Kingdom, Germany, Italy, Netherlands
University of Alabama at Birmingham
Allergan

Completed

Bladder Antimuscarinic Medication and Accidental Bowel Leakage (BAMA)

Fecal Incontinence | Urinary Incontinence, Urge

United States
Pierre and Marie Curie University
APHP

Unknown

French Study to Evaluate the Impact of a Cognitive Therapy on Urinary Incontinent Women of All Age's Perineal Settings.

Urinary Incontinence, Stress | Urinary Incontinence, Urge
Pfizer

Completed

A Trial To Evaluate The Efficacy And Safety Of Fesoterodine In Patients With Symptoms Of Overactive Bladder Including Nocturnal Urinary Urgency

Overactive Bladder

United States
University of Rochester

Terminated

A Study of Transcutaneous Electrical Nerve Stimulation for Overactive Bladder

Overactive Bladder | Urge Incontinence

United States
Hospital de Clinicas de Porto Alegre

Unknown

Comparison of Two Forms of Transcutaneous Electrical Stimulation in Overactive Bladder

Overactive Bladder | Urinary Urge Incontinence

Brazil
Astellas Pharma Europe B.V.

Completed

This Was a Multinational Study Comparing the Efficacy and Safety of Two Medicines , Solifenacin Succinate and Mirabegron Taken Together, or Separately, or a Mock Treatment (Placebo) in Subjects With Symptoms of Overactive Bladder (SYNERGY)

Overactive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic Diseases

United States, Argentina, Australia, Belgium, Bulgaria, Canada, China, Colombia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Malaysia, Mexico, Netherlands and more
University of Alabama at Birmingham
Pfizer

Completed

Detrol Long Acting (LA) vs Estrace Vaginal Cream for the Treatment of Overactive Bladder Symptoms (DRIVE)

Overactive Bladder
Umeå University
Swedish Council for Working Life and Social Research; Jämtland County Council... and other collaborators

Completed

Mobile App-treatment of Mixed and Urgency Urinary Incontinence in Women

Urinary Incontinence

Sweden
Edgar LeClaire, MD

Completed

Reduction of Bladder Injection Pain With Belladonna Opiate Suppository (ROBIN)

Overactive Bladder | Urinary Bladder, Neurogenic | Painful Bladder Syndrome | Urinary Urge Incontinence

United States
Cantonal Hospital of St. Gallen

Completed

Percutaneous Tibial Nerve Stimulation for Patients With Fecal Incontinence

Fecal Incontinence

Switzerland
Astellas Pharma Europe B.V.

Completed

A Multinational Study Comparing the Long-term Efficacy and Safety of Two Medicines, Solifenacin Succinate and Mirabegron Taken Together, or Separately, in Subjects With Symptoms of Overactive Bladder (SYNERGY II)

Overactive Bladder | Urgency Incontinence | Urinary Bladder Overactive | Urinary Bladder Diseases\Urologic Diseases

Belgium, Russian Federation, Korea, Republic of, United States, Germany, Spain, Australia, Bulgaria, Canada, Czechia, Denmark, Estonia, Finland, Hungary, Italy, Latvia, Lithuania, Malaysia, Mexico, Netherlands, New Zealand, Norway, ... and more
Helios Medical Center Schleswig

Unknown

Bilateral Sacrospinous Colposuspension (BSC) in the Female Genital Prolapse With Urinary Urge Symptomatology

Urinary Urge Incontinence

Germany
Astellas Pharma Europe Ltd.

Completed

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) (BESIDE)

Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Overactive

United States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
National Taiwan University Hospital

Completed

Comparisons of Urodynamic, Bladder Diary, Quality of Life Parameters Between OAB-wet and OAB-dry Female Patients (OAB)

Urinary Bladder, Overactive
Tengion

Withdrawn

Autologous Neo-Bladder Construct in Non-Neurogenic Overactive Bladder and Urge Predominant Incontinence

Overactive Bladder

United States
NICHD Pelvic Floor Disorders Network
Eunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaborators

Completed

Refractory Overactive Bladder: Sacral NEuromodulation v. BoTulinum Toxin Assessment (ROSETTA) (ROSETTA)

Urinary Incontinence, Urge

United States
NICHD Pelvic Floor Disorders Network
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Completed

Anticholinergic vs. Botox Comparison Study (ABC)

Overactive Bladder | Urge Urinary Incontinence

United States
University of New Mexico
Society of Urologic Nurses and Associates

Completed

Cycling Versus Continuous Mode in Neuromodulator Programming

Urinary Incontinence, Urge

United States
Lahey Clinic
Astellas Pharma US, Inc.

Terminated

Behavioral Modification and Vesicare Versus Vesicare Alone for Urge Incontinence in Patients With Overactive Bladder

Overactive Bladder

United States
St. Louis University

Withdrawn

Innovative Minimally Invasive Options in Treatment of Urinary Problems Related to Prostate Enlargement (BPH) in Men

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia | Urinary Incontinence, Urge | Nocturia | Incontinence, Urinary | Urinary Frequency/Urgency

United States
Duke University
Society of Urodynamics and Female Pelvic Medicine & Urogenital Reconstruction

Terminated

Comparison of Combination Therapy vs Single Agent Therapy for Treatment of Urge Incontinence. (APP)

Urinary Urge Incontinence

United States
Massachusetts General Hospital

Terminated

Does Percutaneous Tibial Nerve Stimulation (PTNS) Improve Outcomes in Patients Presenting With Fecal Incontinence

Fecal Incontinence

United States
Astellas Pharma Europe Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. (BEYOND)

Urologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases

Greece, Ireland, Armenia, Austria, Belarus, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lebanon, Lithuania, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovaki... and more
MedtronicNeuro

Completed

InSite for Over Active Bladder (InSite - OAB)

Overactive Bladder | Urinary Incontinence, Urgency-frequency
MedtronicNeuro

Completed

InterStim® Sacral Nerve Modulation Cycling Study

Urinary Urge Incontinence

United States
Astellas Pharma Inc

Completed

A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (ARIES)

Urinary Bladder, Overactive

United States, Canada
Astellas Pharma Inc

Completed

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (SCORPIO)

Urinary Bladder, Overactive

Australia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
Astellas Pharma Inc

Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (TAURUS)

Urinary Bladder, Overactive

Canada, Poland, Belgium, Spain, Sweden, United States, Romania, Italy, France, Austria, United Kingdom, Germany, Hungary, Australia, Denmark, Netherlands, Switzerland, Lithuania, Russian Federation, Latvia, South Africa, Slovakia, F... and more
Astellas Pharma Inc

Completed

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (CAPRICORN)

Urinary Bladder, Overactive

United States, Hungary, Canada, Spain, Finland, Slovakia, Czechia, Sweden, Germany, Denmark, Norway

Search clinical trials for: Urge Incontinence

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations